Jan Mattsson, Chief Operating Officer at ALBIREO PHARMA, INC. (ALBO), sold 50,000 shares at $32.19 ($1.6M) on 2018-06-12, disclosed to the SEC on 2018-06-14.
Open-market sale of $1.6M ALBO by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.19 | 15,676 | $505K | 31.3% |
| 2 | $32.19 | 15,676 | $505K | 31.3% |
| 3 | $33.23 | 2,421 | $80K | 5.0% |
| 4 | $33.23 | 2,421 | $80K | 5.0% |
| 5 | $32.08 | 6,903 | $221K | 13.7% |
| 6 | $32.08 | 6,903 |
| $221K |
| 13.7% |
| Total | $32.26 avg | 50,000 | $1.6M | 100% |
| Filing → |
| ALBO | SELL | 2022-10-25 | $4K | — | Filing → |
| ALBO | SELL | 2022-07-25 | $5K | — | Filing → |
| ALBO | SELL | 2022-04-25 | $7K | — | Filing → |